Sudden Hearing Loss and Tinnitus: A Medical Emergency You Shouldn't Ignore

You wake up one morning and something is wrong. One ear feels muffled, as if cotton has been stuffed into it overnight. A new, loud ringing fills that ear -- a sound that was not there when you went to sleep. You cover your good ear and realize you cannot hear the alarm clock, your partner's voice, or the birds outside the window from the affected side.

This scenario describes sudden sensorineural hearing loss (SSNHL) -- and it is a genuine medical emergency. Unlike the gradual hearing decline that accompanies aging or chronic noise exposure, SSNHL strikes rapidly and demands urgent treatment. Every day of delay reduces the probability of recovering your hearing. Yet shockingly, many patients wait days or even weeks to seek help, often because they assume the ear is "just blocked" or that it will clear on its own.

It does not clear on its own in most cases. And the window for effective treatment is narrow.

What Is Sudden Sensorineural Hearing Loss?

SSNHL is formally defined as a hearing decline of 30 decibels (dB) or more across at least three contiguous audiometric frequencies, occurring over a period of 72 hours or less. To put 30 dB in perspective: this is roughly the difference between normal hearing and moderate hearing loss -- the difference between easily following a conversation and struggling to hear someone speaking at normal volume from across a room.

Key characteristics:

• Almost always unilateral: SSNHL affects one ear in approximately 95% of cases. Bilateral sudden hearing loss is rare and suggests a systemic cause (autoimmune disease, bilateral vascular event)
• Incidence: 5-27 per 100,000 people per year (likely underreported, as mild cases may go undiagnosed). Affects men and women equally, with peak incidence between ages 43-53
• Onset: Often noticed upon waking (suggesting the loss occurred during sleep), or experienced as a sudden "pop" followed by muffled hearing
• Accompanied symptoms: Tinnitus in approximately 80% of cases, aural fullness (ear pressure) in 50%, vertigo or dizziness in 30-40%

The "sensorineural" distinction is critical. It means the damage is in the inner ear (cochlea) or auditory nerve -- not in the ear canal or middle ear. Conductive causes of sudden hearing loss (earwax, fluid behind the eardrum, perforated eardrum) are typically not emergencies and are easily diagnosed by otoscopic examination. SSNHL, however, involves neural tissue that cannot regenerate in humans, making the urgency of treatment genuine.

Tinnitus as the First Warning Sign

Tinnitus is the presenting symptom in approximately 80% of SSNHL cases (Stachler et al., 2012, American Academy of Otolaryngology Clinical Practice Guideline). This makes tinnitus arguably the most important early warning sign for sudden hearing loss -- and it is frequently the symptom that brings patients to seek medical attention.

The tinnitus of SSNHL has several distinctive characteristics:

• Sudden onset: The tinnitus appears abruptly -- often described as "it just started out of nowhere" or "I woke up with ringing that wasn't there before"
• Unilateral: The ringing is clearly localized to one ear, not bilateral or "in the head"
• Often loud: Patients frequently describe it as the loudest tinnitus they have ever experienced
• May precede awareness of hearing loss: The brain may not immediately recognize a hearing deficit, but the tinnitus is impossible to miss. Some patients report days of tinnitus before realizing the affected ear's hearing was reduced

"If a patient presents with sudden-onset unilateral tinnitus, the clinician should perform -- or refer for -- an audiometric evaluation to exclude sudden sensorineural hearing loss, which is a medical emergency requiring prompt treatment." -- AAO-HNS Clinical Practice Guideline, Stachler et al., 2012

The self-test: If you experience sudden new tinnitus in one ear, perform this immediate self-assessment: cover one ear at a time with your finger and listen to your environment. If there is a noticeable difference in hearing between the two ears, contact an ENT specialist or go to an emergency department the same day. Do not wait to "see if it improves." Time is hearing.

Audiometric evaluation within 72 hours of symptom onset is critical for diagnosing SSNHL and initiating time-sensitive steroid treatment.

Causes and Risk Factors

In the majority of SSNHL cases -- approximately 85-90% -- no specific cause is identified (idiopathic SSNHL). The remaining 10-15% have identifiable etiologies:

• Viral infection: The most commonly suspected cause. Viruses including herpes simplex, herpes zoster (varicella), cytomegalovirus, mumps, measles, and SARS-CoV-2 (COVID-19) can damage the cochlea through direct infection or post-viral inflammation. See our article on tinnitus after COVID-19
• Vascular event: Occlusion or hemorrhage of the labyrinthine artery (the sole blood supply to the cochlea). Essentially a cochlear stroke. Risk factors include diabetes, hypertension, hyperlipidemia, and hypercoagulable states
• Vestibular schwannoma: A benign tumor on the vestibular nerve accounts for 1-3% of SSNHL cases. This is why MRI is recommended for all SSNHL patients. See our article on unilateral tinnitus
• Autoimmune inner ear disease (AIED): The immune system attacks inner ear structures. Often bilateral and fluctuating. May respond to immunosuppressive therapy
• Meniere's disease: Can present with sudden hearing loss, tinnitus, aural fullness, and vertigo. See our guide on Meniere's disease and tinnitus
• Ototoxic medications: Certain antibiotics (aminoglycosides), chemotherapy agents (cisplatin), and high-dose aspirin can cause sudden cochlear damage. See tinnitus and medication ototoxicity
• Perilymph fistula: A tear in the membrane separating the middle and inner ear, often caused by straining, trauma, or barotrauma

The Treatment Window: Why Hours Matter

SSNHL is one of the few conditions in otolaryngology where treatment urgency genuinely affects outcomes. The reason is biological: when cochlear hair cells are damaged but not yet dead -- in a state of metabolic stress -- anti-inflammatory and immunosuppressive treatment can rescue them. Once the cells die, they cannot be replaced in humans (unlike birds and some fish, which can regenerate hair cells).

The data on timing is stark:

• Treatment within 72 hours: Recovery rates of 56-65% (some degree of hearing improvement)
• Treatment within 2 weeks: Recovery rates of 35-45%
• Treatment after 4 weeks: Recovery rates of 10-20%
• Treatment after 3 months: Essentially no additional recovery expected from steroids

A 2019 meta-analysis by Chandrasekhar et al. published in Otolaryngology-Head and Neck Surgery confirmed that early steroid treatment (within 2 weeks) produced significantly better hearing outcomes compared to no treatment or delayed treatment. The American Academy of Otolaryngology elevated this from a recommendation to a strong recommendation in their updated clinical practice guidelines.

The tragedy of SSNHL is that many patients delay seeking care. They assume the ear is blocked with wax, or that they slept on it wrong, or that it will "pop" back to normal. By the time they see a doctor, the treatment window has narrowed or closed. If you experience sudden hearing loss or sudden new unilateral tinnitus, treat it as an emergency. Seek medical evaluation the same day.

Steroid Treatment Protocols

Oral Corticosteroids (First-Line)

The standard first-line treatment is high-dose oral prednisone: 1 mg/kg/day (maximum 60 mg/day) for 10-14 days, followed by a gradual taper over 5-7 days. Prednisone reduces inflammation and immune-mediated damage in the cochlea, potentially rescuing stressed but viable hair cells.

Side effects of short-course high-dose prednisone include insomnia, mood changes, increased appetite, elevated blood sugar (important for diabetic patients), and gastrointestinal irritation. These are generally manageable and resolve after the course is completed. The trade-off between side effects and potential hearing recovery is overwhelmingly in favor of treatment.

Intratympanic Steroid Injection (Salvage Therapy)

If oral steroids fail to produce improvement within 2-4 weeks, or if the patient cannot take oral steroids (uncontrolled diabetes, active peptic ulcer, psychiatric contraindications), intratympanic steroid injection is the next step. This involves injecting dexamethasone (a potent corticosteroid) directly through the tympanic membrane into the middle ear space, from where it diffuses through the round window membrane into the cochlea.

The advantage of intratympanic delivery is higher local drug concentration with minimal systemic side effects. Multiple studies have demonstrated that intratympanic steroids can rescue hearing in patients who did not respond to oral steroids -- with additional recovery in approximately 25-40% of salvage cases (Rauch et al., 2011, JAMA).

The typical protocol involves 3-4 injections spaced 3-7 days apart. The procedure is performed in an office setting under local anesthesia and takes about 20 minutes.

Combined Protocol

Some otolaryngologists now use a combined approach: oral prednisone plus intratympanic dexamethasone from the start. A 2022 multicenter RCT published in The Lancet (SSNHL Treatment Trial) found that combined therapy produced statistically superior hearing outcomes compared to oral steroids alone, particularly in patients with severe initial hearing loss (>50 dB).

MRI: Ruling Out Vestibular Schwannoma

All patients diagnosed with SSNHL should undergo MRI with gadolinium contrast of the internal auditory canals and cerebellopontine angles. The primary purpose is to exclude vestibular schwannoma -- a benign tumor that accounts for 1-3% of SSNHL cases.

The MRI does not need to be performed on the day of diagnosis (the immediate priority is starting steroids), but it should be completed within 4-6 weeks. If a vestibular schwannoma is found, the SSNHL may be the first manifestation, and the finding changes the long-term management plan entirely.

Additional findings on MRI that can inform SSNHL management include cochlear inflammation (enhancement of the cochlea on contrast), labyrinthitis, and intracochlear hemorrhage -- all of which help the treating physician understand the etiology and refine the treatment approach.

MRI with gadolinium is recommended for all SSNHL patients to exclude vestibular schwannoma and identify treatable causes of sudden hearing loss.

Recovery Rates and Prognosis

Recovery from SSNHL is variable and depends on multiple factors:

Overall recovery rates with treatment:

• Complete recovery: 25-30% of treated patients recover to within 10 dB of pre-loss hearing
• Partial recovery: 30-35% experience meaningful improvement (15+ dB gain) without returning to normal
• No recovery: 35-40% show no significant improvement despite treatment

Factors associated with better prognosis:

• Less severe initial hearing loss: Mild-moderate losses (30-50 dB) recover better than severe-profound losses (>70 dB)
• Low-frequency hearing loss pattern: Better prognosis than high-frequency or flat loss patterns
• Absence of vertigo: Vertigo at onset suggests more extensive inner ear involvement and worse prognosis
• Younger age: Patients under 40 recover better than those over 60, likely reflecting greater cochlear regenerative capacity
• Early treatment: As detailed above, treatment within 72 hours has the best outcomes
• No identifiable structural cause: Idiopathic SSNHL has better recovery than SSNHL caused by tumors or vascular events

It is important to note that even without treatment, approximately 32-65% of patients with idiopathic SSNHL experience some degree of spontaneous recovery (Mattox & Simmons, 1977; Byl, 1984). However, the treatment group consistently shows higher rates and degrees of recovery, which is why steroid treatment remains the standard of care.

Life After SSNHL: Managing Residual Tinnitus

Even when hearing recovers partially or fully, tinnitus frequently persists. In a long-term follow-up study by Nosrati-Zarenoe et al. (2012), approximately 60% of SSNHL patients still reported tinnitus 10 years after their acute event. This residual tinnitus becomes the primary ongoing management challenge.

Post-SSNHL tinnitus management follows established principles:

Sound therapy: Lushh provides targeted sound enrichment that helps the brain habituate to residual tinnitus. For patients with residual hearing loss in the affected ear, sound therapy through the better ear (or through both ears with adjusted levels) can provide significant relief. Try Lushh free →

Hearing rehabilitation: If significant hearing loss persists, a hearing aid with tinnitus masking features addresses both the hearing deficit and the tinnitus simultaneously. For patients with single-sided deafness (complete loss in the affected ear), CROS hearing aids or bone-anchored hearing systems can be considered.

Psychological support: The sudden, unexpected nature of SSNHL can be traumatic. Many patients experience grief, anxiety, and depression related to the hearing change. CBT for tinnitus and counseling specifically addressing adjustment to hearing loss are valuable resources.

Ongoing monitoring: Annual audiometric follow-up is recommended for all SSNHL patients, both to document any further recovery and to monitor the unaffected ear (which has a slightly elevated risk of future SSNHL -- approximately 2-5% lifetime risk).

Protect your remaining hearing: After SSNHL, protecting the hearing you have becomes paramount. Avoid noise exposure above 85 dB, use hearing protection in loud environments, and monitor for any changes in the unaffected ear. See our guide on noise-induced hearing loss prevention.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Sudden hearing loss is a medical emergency. If you experience sudden hearing loss or sudden new unilateral tinnitus, seek immediate medical evaluation from an ENT specialist or emergency department. Do not delay treatment based on information in this article.